Mumbai, October 14, 2024: LupinLife, the consumer healthcare division of global pharma major Lupin Limited (Lupin) today announced the flag-off of its Aptivate Achi Bhookh Fest in Mumbai and its suburbs. The fest aims to create awareness around the significance of optimal good nutrition for children to enable holistic health and stronger immunity and helps mothers in encouraging healthy eating habits. The event features multiple on-ground activities, sessions led by expert nutritionists, yoga, puzzles and fun games.

The first phase of the Aptivate Achi Bhookh Fest reached over 8,200 households and 29,200 people across 17 residential complexes. In the next few months, the fest will extend to over 100 residential complexes, schools and educational institutions, and is projected to reach 250,000 people.

Anil V Kaushal, Business Head, LupinLife said, “A healthier generation of children paves the way for a stronger and more robust society and nation. We believe that through the Aptivate Achi Bhookh Fest, we are enabling good eating habits in children and providing guidance on leading an active lifestyle from an early age.”

Aptivate is an ayurvedic appetite stimulant for children that enables parents to promote healthy eating habits. Over the past three years, the brand has taken significant steps in this direction through various initiatives under Achi Bhookh campaign such as the Aptivate Champion Run, the Hindustan Times School Quiz, and now the Aptivate Achi Bhookh Fest.

About Lupin
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 22,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
To know more, visit www.lupin.com or follow us on LinkedIn https://www.linkedin.com/company/lupin

For further information or queries please contact –
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications, Lupin
rajalakshmiazariah@lupin.com